Compare KRYS & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | KEX |
|---|---|---|
| Founded | 2015 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.6B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | KEX |
|---|---|---|
| Price | $298.90 | $143.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $297.60 | $137.25 |
| AVG Volume (30 Days) | 273.5K | ★ 606.7K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 28.92 |
| EPS | ★ 1.83 | 1.50 |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $4.34 |
| Revenue Next Year | $32.53 | $7.61 |
| P/E Ratio | $166.58 | ★ $96.77 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $79.52 |
| 52 Week High | $319.48 | $157.69 |
| Indicator | KRYS | KEX |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 47.62 |
| Support Level | $253.89 | $140.14 |
| Resistance Level | $319.48 | $157.69 |
| Average True Range (ATR) | 11.79 | 3.85 |
| MACD | -0.87 | -0.50 |
| Stochastic Oscillator | 46.86 | 36.30 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.